miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease

Figure 1 Differential expression of microRNA-103 levels in the serum of patients with nonalcoholic fatty liver disease. microRNA (miR)-103 was log-transformed before analysis because it was not normally distributed. ^aP < 0.05 vs normal control group (unpaired Student t test). NAFLD: Nonalcoholic fatty liver disease.

Figure 2 Correlation between microRNA-103 and Triglycerides (A), Homeostasis model assessment-insulin resistance (B), and body mass index (C). A: microRNA (miR)-103 was positively correlated with Triglycerides (TG) (r = 0.774, P = 0.01, bilateral); B: miR-103 was positively correlated with Homeostasis model assessment-insulin resistance (HOMA-IR) (r = 0.881, P = 0.01, bilateral); C: miR-103 was positively correlated with body mass index (BMI) (r = 0.878, P = 0.01, bilateral).